ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
IQVIA at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
IQVIA takes part in 3 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1001. Its work focuses on treatment decisions and patient evidence in cancer care. It examines factors that may guide first treatment for head and neck cancer and how patient-reported outcomes affect reimbursement decisions.
| Organization | ESMO 2026 Attendance |
|---|---|
Global contract research and healthcare data company providing clinical trial services and real-world evidence. | Booth Exhibiting at Booth 1001 Poster Fri Oct 23 13:00–15:00 Optimizing first-line treatment in R/M head and neck cancer: Systematic review of prognostic, predictive, and effect modifying factors Sarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 13:00–15:00 THRIVE-20-PF Spanish validation and a stepwise framework for psychometric evaluation and benchmarking in oncology Gastrointestinal cancersNursing & supportive care Satellite Sun Oct 25 19:45–19:55 How Do Patient-Reported Outcomes Influence Reimbursement Decisions? Nursing & supportive care |
Find decision makers at IQVIA
Tell us what you sell and we’ll find the people at IQVIA most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction